pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Nephrology · news · pharmadog
← back to Nephrology
News · Nephrology
282
stories
Aug 20, 26
Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impact
fiercebiotech
Aug 20, 26
Reduce protein to increase longevity? Nutrition experts say that’s a bad idea
stat
Aug 20, 26
7 biopharma M&A deals where layoffs followed
biospace
Aug 19, 26
Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goal
biospace
Aug 19, 26
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
biopharma dive
Aug 18, 26
STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
stat
Aug 17, 26
Vera’s newly approved IgA nephropathy drug supports kidney function, like Otsuka’s Voyxact
biospace
Aug 14, 26
Skye and Redx form new entity with $125M to advance fibrosis assets
fiercebiotech
Aug 14, 26
Pressure piles on Amgen after EU pulls Tavneos, flags 'serious breaches' in pivotal study
biospace
Aug 13, 26
Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale
biospace
Aug 12, 26
BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations
biospace
Aug 12, 26
Boulevard starts up with $65M to pursue targeted autoimmune drugs
biopharma dive
Aug 12, 26
Opinion: Climate change is making people with chronic illness even sicker
stat
Aug 11, 26
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
fiercebiotech
Aug 10, 26
AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant
biospace
Aug 7, 26
BioMarin axes $270M rare disease asset after missing phase 3 endpoint
fiercebiotech
Aug 6, 26
U.S. moves to shut a Kentucky organ donation group, citing safety failures
stat
Aug 6, 26
With $263M, LifeMine unearths a new drug for organ transplants
biopharma dive
Aug 6, 26
LifeMine raises $263M in mission to improve organ transplant aftercare
biospace
Aug 6, 26
Opinion: STAT+: Stop asking if AI is good for medicine
stat
Aug 5, 26
‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series E
fiercebiotech
Aug 5, 26
Attovia adds to biotech IPO momentum with $289M offering
biopharma dive
Aug 5, 26
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
biospace
Aug 5, 26
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
stat
Aug 5, 26
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
Aug 4, 26
Otsuka succeeds with kidney drug; BioNTech downgrades revenue projection
endpoints
Aug 4, 26
Vertex unfazed by competitive IgAN space as FDA verdict looms
biospace
Aug 3, 26
STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
stat
Aug 3, 26
Amgen hit with cybersecurity breach, patient data affected
biospace
Jul 31, 26
Novo setback casts doubt on a new way to treat heart disease
biopharma dive
← prev
page 6 of 10
next →